Sacubitril 24mg + Valsartan 26mg is a combination medication used to manage heart failure with reduced ejection fraction (HFrEF). Sacubitril is a neprilysin inhibitor that enhances levels of natriuretic peptides, promoting vasodilation, diuresis, and sodium excretion. Valsartan is an angiotensin II receptor blocker (ARB) that reduces blood pressure, decreases strain on the heart, and prevents heart remodeling. Together, this combination improves cardiac function, reduces hospitalizations, and enhances quality of life in patients with chronic heart failure. This medicine is available in tablet form and is prescribed under medical supervision. Regular monitoring of kidney function, blood pressure, and electrolyte levels is recommended during therapy.
